Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection

Infection with hepatitis B virus (HBV) genotype G has been associated with increased liver fibrosis levels compared with other genotypes in cross‐sectional studies, yet its role in fibrosis evolution remains to be established.

[1]  S. Luchters,et al.  Factors associated with HIV testing among young men who have sex with men in Myanmar: a cross‐sectional study , 2017, Journal of the International AIDS Society.

[2]  S. Lewin,et al.  HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment , 2017, AIDS.

[3]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[4]  K. Lacombe,et al.  Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV–HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study , 2017, Journal of the International AIDS Society.

[5]  Richard D Moore,et al.  Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  W. Lu,et al.  Measurement of the hepatitis B core-related antigen is valuable for predicting the pathological status of liver tissues in chronic hepatitis B patients. , 2016, Journal of virological methods.

[7]  B. Berkhout,et al.  Widespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with men , 2016, BMC Infectious Diseases.

[8]  P. Revill,et al.  Overview of hepatitis B viral replication and genetic variability. , 2016, Journal of hepatology.

[9]  F. Zoulim,et al.  Rates and determinants of hepatitis B ‘e’ antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus , 2015, AIDS.

[10]  F. Carrat,et al.  Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[11]  M. N. Kim,et al.  Long‐term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[12]  M. Kretzschmar,et al.  Targeted vaccination programme successful in reducing acute hepatitis B in men having sex with men in Amsterdam, the Netherlands. , 2013, Journal of hepatology.

[13]  C. Katlama,et al.  Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  F. Zoulim,et al.  High incidence of treatment‐induced and vaccine‐escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B–infected patients , 2013, Hepatology.

[15]  John F. Flaherty,et al.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study , 2013, The Lancet.

[16]  Laurent Castera,et al.  Noninvasive methods to assess liver disease in patients with hepatitis B or C. , 2012, Gastroenterology.

[17]  William M. Lee,et al.  Hepatitis B virus genotype G: Prevalence and impact in patients co‐infected with human immunodeficiency virus , 2011, Journal of medical virology.

[18]  S. Lewin,et al.  Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression , 2011, AIDS.

[19]  P. Marcellin,et al.  Response to antiviral treatment in patients infected with hepatitis B virus genotypes E–H , 2009, Journal of medical virology.

[20]  D. Wendum,et al.  Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. , 2009, Journal of hepatology.

[21]  Chien-Jen Chen,et al.  Hepatitis B virus DNA levels and outcomes in chronic hepatitis B , 2009, Hepatology.

[22]  J. Villeneuve,et al.  Hepatitis B virus genotype G epidemiology and co-infection with genotype A in Canada. , 2008, The Journal of general virology.

[23]  Chien-Jen Chen,et al.  Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.

[24]  M. Sugiyama,et al.  Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes. , 2008, Virology.

[25]  C. Niel,et al.  Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil , 2008 .

[26]  M. Desvarieux,et al.  The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients , 2007, AIDS.

[27]  N. Izumi,et al.  Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens , 2006, Hepatology.

[28]  F. Carrat,et al.  Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV , 2006, AIDS.

[29]  C. Chu,et al.  Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. , 2005, Journal of hepatology.

[30]  D. Blondin,et al.  Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D , 2005, Gut.

[31]  V. Wong,et al.  Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma , 2004, Gut.

[32]  Ching-Lung Lai,et al.  Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. , 2004, Carcinogenesis.

[33]  M. Manns,et al.  A comparison of fibrosis progression in chronic liver diseases. , 2003, Journal of hepatology.

[34]  F. Sugauchi,et al.  Characteristics of Hepatitis B Virus Isolates of Genotype G and Their Phylogenetic Differences from the Other Six Genotypes (A through F) , 2002, Journal of Virology.

[35]  Ding‐Shinn Chen,et al.  Hepatitis B genotypes and the response to interferon therapy. , 2000, Journal of hepatology.

[36]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[37]  R F Schinazi,et al.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. , 2000, The Journal of general virology.